Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants
Gespeichert in:
| Titel: | Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants |
|---|---|
| Autoren: | Anzalone, A Jerrod, Beasley, William H, Murray, Kimberly, Hillegass, William B, Schissel, Makayla, Vest, Michael T, Chapman, Scott A, Horswell, Ronald, Miele, Lucio, Santangelo, Susan, Rosen, Clifford J |
| Quelle: | MaineHealth Maine Medical Center |
| Verlagsinformationen: | MaineHealth Knowledge Connection |
| Publikationsjahr: | 2025 |
| Bestand: | MaineHealth Knowledge Connection |
| Schlagwörter: | COVID‐19 Therapies, Mortality, National COVID Cohort Collaborative (N3C), SARS‐CoV‐2, Urban‐Rural Health, Humans, Male, Female, SARS-CoV-2, COVID-19 (epidemiology, prevention & control, mortality), Urban Population (statistics & numerical data), Retrospective Studies, Rural Population (statistics & numerical data), Middle Aged, United States (epidemiology), Aged, Adult, COVID-19 Drug Treatment, Antiviral Agents (therapeutic use), Hospitalization (statistics & numerical data), COVID-19 Vaccines (therapeutic use, administration & dosage) |
| Beschreibung: | PURPOSE: To investigate the enduring disparities in adverse COVID-19 events between urban and rural communities in the United States, focusing on the effects of SARS-CoV-2 vaccination and therapeutic advances on patient outcomes. METHODS: Using National COVID Cohort Collaborative (N3C) data from 2021 to 2023, this retrospective cohort study examined COVID-19 hospitalization, inpatient death, and other adverse events. Populations were categorized into urban, urban-adjacent rural (UAR), and nonurban-adjacent rural (NAR). Adjustments included demographics, variant-dominant waves, comorbidities, region, and SARS-CoV-2 treatment and vaccination. Statistical methods included Kaplan-Meier survival estimates, multivariable logistic, and Cox regression. FINDINGS: The study included 3,018,646 patients, with rural residents constituting 506,204. These rural dwellers were older, had more comorbidities, and were less vaccinated than their urban counterparts. Adjusted analyses revealed higher hospitalization odds in UAR and NAR (aOR 1.07 [1.05-1.08] and 1.06 [1.03-1.08]), greater inpatient death hazard (aHR 1.30 [1.26-1.35] UAR and 1.37 [1.30-1.45] NAR), and greater risk of other adverse events compared to urban dwellers. Delta increased, while Omicron decreased, inpatient adverse events relative to pre-Delta, with rural disparities persisting throughout. Treatment effectiveness and vaccination were similarly protective across all cohorts, but dexamethasone post-ventilation was effective only in urban areas. Nirmatrelvir/ritonavir and molnupiravir better protected rural residents against hospitalization. CONCLUSIONS: Despite advancements in treatment and vaccinations, disparities in adverse COVID-19 outcomes persist between urban and rural communities. The effectiveness of some therapeutic agents appears to vary based on rurality, suggesting a nuanced relationship between treatment and geographic location while highlighting the need for targeted rural health care strategies. |
| Publikationsart: | text |
| Sprache: | unknown |
| Relation: | https://knowledgeconnection.mainehealth.org/mmc/3888; https://pubmed.ncbi.nlm.nih.gov/38953158/ |
| Verfügbarkeit: | https://knowledgeconnection.mainehealth.org/mmc/3888 https://pubmed.ncbi.nlm.nih.gov/38953158/ |
| Dokumentencode: | edsbas.C3DE08F9 |
| Datenbank: | BASE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://knowledgeconnection.mainehealth.org/mmc/3888# Name: EDS - BASE (s4221598) Category: fullText Text: View record from BASE – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Anzalone%20AJ Name: ISI Category: fullText Text: Nájsť tento článok vo Web of Science Icon: https://imagesrvr.epnet.com/ls/20docs.gif MouseOverText: Nájsť tento článok vo Web of Science |
|---|---|
| Header | DbId: edsbas DbLabel: BASE An: edsbas.C3DE08F9 RelevancyScore: 939 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 939.3056640625 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Anzalone%2C+A+Jerrod%22">Anzalone, A Jerrod</searchLink><br /><searchLink fieldCode="AR" term="%22Beasley%2C+William+H%22">Beasley, William H</searchLink><br /><searchLink fieldCode="AR" term="%22Murray%2C+Kimberly%22">Murray, Kimberly</searchLink><br /><searchLink fieldCode="AR" term="%22Hillegass%2C+William+B%22">Hillegass, William B</searchLink><br /><searchLink fieldCode="AR" term="%22Schissel%2C+Makayla%22">Schissel, Makayla</searchLink><br /><searchLink fieldCode="AR" term="%22Vest%2C+Michael+T%22">Vest, Michael T</searchLink><br /><searchLink fieldCode="AR" term="%22Chapman%2C+Scott+A%22">Chapman, Scott A</searchLink><br /><searchLink fieldCode="AR" term="%22Horswell%2C+Ronald%22">Horswell, Ronald</searchLink><br /><searchLink fieldCode="AR" term="%22Miele%2C+Lucio%22">Miele, Lucio</searchLink><br /><searchLink fieldCode="AR" term="%22Santangelo%2C+Susan%22">Santangelo, Susan</searchLink><br /><searchLink fieldCode="AR" term="%22Rosen%2C+Clifford+J%22">Rosen, Clifford J</searchLink> – Name: TitleSource Label: Source Group: Src Data: MaineHealth Maine Medical Center – Name: Publisher Label: Publisher Information Group: PubInfo Data: MaineHealth Knowledge Connection – Name: DatePubCY Label: Publication Year Group: Date Data: 2025 – Name: Subset Label: Collection Group: HoldingsInfo Data: MaineHealth Knowledge Connection – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22COVID‐19+Therapies%22">COVID‐19 Therapies</searchLink><br /><searchLink fieldCode="DE" term="%22Mortality%22">Mortality</searchLink><br /><searchLink fieldCode="DE" term="%22National+COVID+Cohort+Collaborative+%28N3C%29%22">National COVID Cohort Collaborative (N3C)</searchLink><br /><searchLink fieldCode="DE" term="%22SARS‐CoV‐2%22">SARS‐CoV‐2</searchLink><br /><searchLink fieldCode="DE" term="%22Urban‐Rural+Health%22">Urban‐Rural Health</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Male%22">Male</searchLink><br /><searchLink fieldCode="DE" term="%22Female%22">Female</searchLink><br /><searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+%28epidemiology%22">COVID-19 (epidemiology</searchLink><br /><searchLink fieldCode="DE" term="%22prevention+%26+control%22">prevention & control</searchLink><br /><searchLink fieldCode="DE" term="%22mortality%29%22">mortality)</searchLink><br /><searchLink fieldCode="DE" term="%22Urban+Population+%28statistics+%26+numerical+data%29%22">Urban Population (statistics & numerical data)</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+Studies%22">Retrospective Studies</searchLink><br /><searchLink fieldCode="DE" term="%22Rural+Population+%28statistics+%26+numerical+data%29%22">Rural Population (statistics & numerical data)</searchLink><br /><searchLink fieldCode="DE" term="%22Middle+Aged%22">Middle Aged</searchLink><br /><searchLink fieldCode="DE" term="%22United+States+%28epidemiology%29%22">United States (epidemiology)</searchLink><br /><searchLink fieldCode="DE" term="%22Aged%22">Aged</searchLink><br /><searchLink fieldCode="DE" term="%22Adult%22">Adult</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+Drug+Treatment%22">COVID-19 Drug Treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Antiviral+Agents+%28therapeutic+use%29%22">Antiviral Agents (therapeutic use)</searchLink><br /><searchLink fieldCode="DE" term="%22Hospitalization+%28statistics+%26+numerical+data%29%22">Hospitalization (statistics & numerical data)</searchLink><br /><searchLink fieldCode="DE" term="%22COVID-19+Vaccines+%28therapeutic+use%22">COVID-19 Vaccines (therapeutic use</searchLink><br /><searchLink fieldCode="DE" term="%22administration+%26+dosage%29%22">administration & dosage)</searchLink> – Name: Abstract Label: Description Group: Ab Data: PURPOSE: To investigate the enduring disparities in adverse COVID-19 events between urban and rural communities in the United States, focusing on the effects of SARS-CoV-2 vaccination and therapeutic advances on patient outcomes. METHODS: Using National COVID Cohort Collaborative (N3C) data from 2021 to 2023, this retrospective cohort study examined COVID-19 hospitalization, inpatient death, and other adverse events. Populations were categorized into urban, urban-adjacent rural (UAR), and nonurban-adjacent rural (NAR). Adjustments included demographics, variant-dominant waves, comorbidities, region, and SARS-CoV-2 treatment and vaccination. Statistical methods included Kaplan-Meier survival estimates, multivariable logistic, and Cox regression. FINDINGS: The study included 3,018,646 patients, with rural residents constituting 506,204. These rural dwellers were older, had more comorbidities, and were less vaccinated than their urban counterparts. Adjusted analyses revealed higher hospitalization odds in UAR and NAR (aOR 1.07 [1.05-1.08] and 1.06 [1.03-1.08]), greater inpatient death hazard (aHR 1.30 [1.26-1.35] UAR and 1.37 [1.30-1.45] NAR), and greater risk of other adverse events compared to urban dwellers. Delta increased, while Omicron decreased, inpatient adverse events relative to pre-Delta, with rural disparities persisting throughout. Treatment effectiveness and vaccination were similarly protective across all cohorts, but dexamethasone post-ventilation was effective only in urban areas. Nirmatrelvir/ritonavir and molnupiravir better protected rural residents against hospitalization. CONCLUSIONS: Despite advancements in treatment and vaccinations, disparities in adverse COVID-19 outcomes persist between urban and rural communities. The effectiveness of some therapeutic agents appears to vary based on rurality, suggesting a nuanced relationship between treatment and geographic location while highlighting the need for targeted rural health care strategies. – Name: TypeDocument Label: Document Type Group: TypDoc Data: text – Name: Language Label: Language Group: Lang Data: unknown – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://knowledgeconnection.mainehealth.org/mmc/3888; https://pubmed.ncbi.nlm.nih.gov/38953158/ – Name: URL Label: Availability Group: URL Data: https://knowledgeconnection.mainehealth.org/mmc/3888<br />https://pubmed.ncbi.nlm.nih.gov/38953158/ – Name: AN Label: Accession Number Group: ID Data: edsbas.C3DE08F9 |
| PLink | https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsbas&AN=edsbas.C3DE08F9 |
| RecordInfo | BibRecord: BibEntity: Languages: – Text: unknown Subjects: – SubjectFull: COVID‐19 Therapies Type: general – SubjectFull: Mortality Type: general – SubjectFull: National COVID Cohort Collaborative (N3C) Type: general – SubjectFull: SARS‐CoV‐2 Type: general – SubjectFull: Urban‐Rural Health Type: general – SubjectFull: Humans Type: general – SubjectFull: Male Type: general – SubjectFull: Female Type: general – SubjectFull: SARS-CoV-2 Type: general – SubjectFull: COVID-19 (epidemiology Type: general – SubjectFull: prevention & control Type: general – SubjectFull: mortality) Type: general – SubjectFull: Urban Population (statistics & numerical data) Type: general – SubjectFull: Retrospective Studies Type: general – SubjectFull: Rural Population (statistics & numerical data) Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: United States (epidemiology) Type: general – SubjectFull: Aged Type: general – SubjectFull: Adult Type: general – SubjectFull: COVID-19 Drug Treatment Type: general – SubjectFull: Antiviral Agents (therapeutic use) Type: general – SubjectFull: Hospitalization (statistics & numerical data) Type: general – SubjectFull: COVID-19 Vaccines (therapeutic use Type: general – SubjectFull: administration & dosage) Type: general Titles: – TitleFull: Associations between COVID-19 therapies and outcomes in rural and urban America: A multisite, temporal analysis from the Alpha to Omicron SARS-CoV-2 variants Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Anzalone, A Jerrod – PersonEntity: Name: NameFull: Beasley, William H – PersonEntity: Name: NameFull: Murray, Kimberly – PersonEntity: Name: NameFull: Hillegass, William B – PersonEntity: Name: NameFull: Schissel, Makayla – PersonEntity: Name: NameFull: Vest, Michael T – PersonEntity: Name: NameFull: Chapman, Scott A – PersonEntity: Name: NameFull: Horswell, Ronald – PersonEntity: Name: NameFull: Miele, Lucio – PersonEntity: Name: NameFull: Santangelo, Susan – PersonEntity: Name: NameFull: Rosen, Clifford J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Type: published Y: 2025 Identifiers: – Type: issn-locals Value: edsbas Titles: – TitleFull: MaineHealth Maine Medical Center Type: main |
| ResultId | 1 |
Nájsť tento článok vo Web of Science